Report overview
The global Therapeutic Recombinant Protein market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Hormones Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Recombinant Protein include Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems and Abnova, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Recombinant Protein. This report contains market size and forecasts of Therapeutic Recombinant Protein in global, including the following market information:
Global Therapeutic Recombinant Protein Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Therapeutic Recombinant Protein companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Recombinant Protein Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, by Type, 2023 (%)
Hormones
Blood Clotting Factors
Cytokines
Enzymes
Fusion Proteins
Others
Global Therapeutic Recombinant Protein Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, by Application, 2023 (%)
Pharmaceutical Company
Research Institute
Others
Global Therapeutic Recombinant Protein Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Recombinant Protein revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Therapeutic Recombinant Protein revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Recombinant Protein, market overview.
Chapter 2: Global Therapeutic Recombinant Protein market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Recombinant Protein company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Recombinant Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
